CVS Health plans to split into two publicly traded companies by the first half of 2028, according to CNBC. One company would hold the pharmacy business, including roughly 9,000 retail locations. The other would hold the insurance business, Aetna, and the pharmacy benefit manager, Caremark.

CVS CEO David Joyner told CNBC's "Squawk on the Street" that in 2024 the company was "in a turnaround" without the flexibility, cash or performance to execute a split. He told analysts on a call Wednesday that the decision comes "out of strength." CVS has posted eight consecutive quarters of beating Wall Street earnings estimates, and it expects at least $15.5 billion in operating cash flow in 2026, up from $9.1 billion in 2024, the report says.

Analysts cited in the report say the retail pharmacy has become more consistently profitable. Brian Tanquilut of Jefferies said that "back then, the idea of retail standing alone was unthinkable," referring to the period when CVS last considered a breakup more than two years ago. Michael Cherny of Leerink Partners called the pharmacy "much different" from its past. The retail segment still runs adjusted operating margins of roughly 4% to 5%, according to the report.

Aetna has improved its performance, according to the report, by exiting unprofitable markets, expanding value-based care and tightening utilization management. The report also says that analysts expect the retail pharmacy to trade at a discount to CVS's other businesses.

CVS shares fell about 12% after the announcement, the report says. Joyner told the Wall Street Journal the split is not driven by regulatory issues, though the report notes that Caremark faces state-level legal and regulatory scrutiny, and that Tennessee and Arkansas have passed laws that would bar one company from owning both a pharmacy and a PBM. The report says the Arkansas measure has been held up in court.